(MedPage Today) -- These days, we're overwhelmed with data. Every chart on every patient is packed full of data -- some of it incredibly useful and important, some of it just a lot of noise, some of it just copy-and-pasted and brought forward...
(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of generalized myasthenia gravis, whether...
(MedPage Today) -- SAN DIEGO -- Clearance of circulating tumor (ct)DNA after neoadjuvant therapy correlated significantly with pathologic complete response (pCR) and distant metastasis in triple-negative breast cancer (TNBC), according to a study...
(MedPage Today) -- Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries, and conferences dedicated to the mind-altering substances. Now add one more business to the list: psychedelic retreats....